Filters

Drug safety

Showing results (1911-1920 of 3,086) with videos related to

Pageof 309
Sort By:
Drug Safety|April 22, 2008
The European Herbal Medicines Directive: could it have saved the lives of Romeo and Juliet?Philip A Routledge
Drug Safety|April 22, 2008
European legislation on herbal medicines: a look into the futureGioacchino Calapai
Drug Safety|April 22, 2008
Understanding the adverse effects of cosmetics: a pilot project in cosmetovigilanceLidia Sautebin
Drug Safety|April 22, 2008
Assessment of the risk of fragrance allergy in the general population: challenges and methodological issuesLuigi Naldi
Drug Safety|February 6, 1999
Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patientsN Principi, S Esposito
Drug Safety|February 6, 1999
A risk-benefit assessment of abciximab in angioplastyN S Kleiman
Drug Safety|February 6, 1999
Inhaled corticosteroids and cataract: prevalence, prevention and managementR G Cumming, P Mitchell
Drug Safety|January 8, 1999
Nonsteroidal anti-inflammatory drugs and cognitive function: do they have a beneficial or deleterious effect?T M Karplus, K G Saag
Drug Safety|January 8, 1999
Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacologyA Nordberg, A L Svensson
Drug Safety|January 8, 1999
Treatment of concomitant illnesses in patients receiving anticonvulsants: drug interactions of clinical significanceP Loiseau
Pageof 309

Showing results (1911-1920 of 3,086) with videos related to

Sort By:
Pageof 309
Drug Safety|April 22, 2008
The European Herbal Medicines Directive: could it have saved the lives of Romeo and Juliet?Philip A Routledge
Drug Safety|April 22, 2008
European legislation on herbal medicines: a look into the futureGioacchino Calapai
Drug Safety|April 22, 2008
Understanding the adverse effects of cosmetics: a pilot project in cosmetovigilanceLidia Sautebin
Drug Safety|April 22, 2008
Assessment of the risk of fragrance allergy in the general population: challenges and methodological issuesLuigi Naldi
Drug Safety|February 6, 1999
Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patientsN Principi, S Esposito
Drug Safety|February 6, 1999
A risk-benefit assessment of abciximab in angioplastyN S Kleiman
Drug Safety|February 6, 1999
Inhaled corticosteroids and cataract: prevalence, prevention and managementR G Cumming, P Mitchell
Drug Safety|January 8, 1999
Nonsteroidal anti-inflammatory drugs and cognitive function: do they have a beneficial or deleterious effect?T M Karplus, K G Saag
Drug Safety|January 8, 1999
Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacologyA Nordberg, A L Svensson
Drug Safety|January 8, 1999
Treatment of concomitant illnesses in patients receiving anticonvulsants: drug interactions of clinical significanceP Loiseau
Pageof 309
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us